Amoxapine

Amoxapine

SCHEMBL29370074

Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

DRD1DRD2DRD3DRD4DRD5SLC6A2SLC6A4

The experimentally established mechanism targets of Amoxapine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD2 known ✓ P14416 8/20 1.00
DRD4 known ✓ P21917 5/20 1.00
DRD3 known ✓ P35462 5/20 1.00
DRD1 known ✓ P21728 3/20 1.00
DRD5 known ✓ P21918 2/20 1.00
SLC6A2 known ✓ P23975 2/20 1.00
SLC6A4 known ✓ P31645 2/20 1.00
CHRM1 P11229 5/20 1.00
HTR1A P08908 3/20 1.00
ADRA2A P08913 3/20 1.00
HTR2A P28223 3/20 1.00
HRH2 P25021 3/20 1.00
HRH1 P35367 3/20 1.00
CHRM2 P08172 3/20 1.00
CHRM4 P08173 3/20 1.00
CHRM5 P08912 3/20 1.00
CHRM3 P20309 3/20 1.00
KCNH2 Q12809 3/20 1.00
CYP1A2 P05177 3/20 1.00
CYP3A4 P08684 3/20 1.00

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Amoxapine SCHEMBL29482386 1.00 DRD2 (1.00) DRD2DRD4CHRM1DRD3HTR1A
Amoxapine SCHEMBL5498936 1.00 DRD2 (1.00) DRD2DRD4CHRM1DRD3HTR1A
Amoxapine SCHEMBL29354942 1.00 DRD2 (1.00) DRD2DRD4CHRM1DRD3HTR1A
Amoxapine SCHEMBL33950 1.00 DRD2 (1.00) DRD2DRD4CHRM1DRD3HTR1A
Amoxapine SCHEMBL29180215 0.99 DRD2 (0.98) DRD2DRD4CHRM1DRD3HTR1A
Amoxapine SCHEMBL8741185 0.96 DRD2 (0.93) DRD2DRD4CHRM1DRD3HTR1A
SCHEMBL2738976 0.90 DRD4 (0.82) DRD2DRD4CHRM1DRD3HTR1A
SCHEMBL3409689 0.89 DRD2 (0.80) DRD2DRD4CHRM1DRD3HTR1A
SCHEMBL25410757 0.87 HRH4 (0.77) DRD2DRD4CHRM1DRD3HTR1A
Amoxapine SCHEMBL21225243 0.87 DRD2 (0.76) DRD2DRD4CHRM1DRD3HTR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 94 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116109155-B Method and device for evaluating longitudinal connectivity of dam-built river 中国长江三峡集团有限公司 2025-03-07 CN claimed
CN-119527997-A Escalator load dynamic monitoring method and system 吴晓军 2025-02-28 CN claimed
CN-119069126-A Postpartum anemia risk prediction model and application method thereof 汤臣倍健股份有限公司 2024-12-03 CN claimed
CN-114020730-B Method for detecting and repairing abnormal value in water environment monitoring data 河北科技师范学院 2024-09-13 CN claimed
CN-118092526-A Safety regulation control system for music performance stage equipment 黑河学院 2024-05-28 CN claimed
CN-112162694-B Data transmission speed control method and device 合肥中科君达视界技术股份有限公司 2024-05-07 CN claimed
CN-116049686-A Railway direct-current relay running state evaluation method based on distance measurement 沈阳工业大学 2023-05-02 CN claimed
CN-115952694-A QAR data-based wind shear operation manipulation quality evaluation method in approach stage 中国民用航空飞行学院 2023-04-11 CN claimed
CN-115617380-A Batch generation method for updating installation package in incremental mode 江铃汽车股份有限公司 2023-01-17 CN claimed
CN-114891913-A Primer group for judging optimal application period of grape color-changing fertilizer and application of primer group 南京农业大学 2022-08-12 CN claimed
CN-114584203-A Satellite-ground link uplink data transmission method based on multi-beam satellite 四川轻化工大学 2022-06-03 CN claimed
CN-114329305-A TLE-based star link target state estimation method and system 中国电子科技集团公司第三十八研究所 2022-04-12 CN claimed
CN-111523814-B Intelligent planning method for urban rail transit schedule and vehicle bottom application plan 西南交通大学 2022-02-11 CN claimed
US-20260094374-A1 HIGH-FIDELITY 3D MESH GENERATION VIA NEURAL NETWORKS NVIDIA CORP (US) 2026-04-02 US disclosed
EP-4705901-A1 SYSTEMS AND METHODS FOR EXPLORING QUANTIFIABLE TRENDS IN LINE CHARTS Salesforce, Inc. (US) 2026-03-11 EP disclosed
US-20260060802-A1 AORTIC VALVE REPLACEMENT PROSTHESIS NANJING SAINT MEDICAL TECH CO LTD (CN) 2026-03-05 US disclosed
CN-114044473-A Large-scale indoor installation machineshop car based on intelligence speech control 泰州机电高等职业技术学校 2022-02-15 CN disclosed
CN-111523814-B Intelligent planning method for urban rail transit schedule and vehicle bottom application plan 西南交通大学 2022-02-11 CN disclosed
CN-215768914-U Complete set of test device for iron loss test 武汉恒盛兴电力自动化有限公司 2022-02-08 CN disclosed
US-11238020-B2 Maintaining temporal associations for event data in an event database EMC IP Holding Company LLC (US) 2022-02-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260060802-A1 AORTIC VALVE REPLACEMENT PROSTHESIS SEM1, ATP2A1, PSMA1 DRD2 4175/4885DRD4 4541/4885DRD3 4345/4885
US-20260094374-A1 HIGH-FIDELITY 3D MESH GENERATION VIA NEURAL NETWORKS HTR3D, NCDN, GFRA3 DRD2 475/4885DRD4 435/4885DRD3 93/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.